Keros Therapeutics, Inc. (KROS) Profit Margin
Keros Therapeutics, Inc. (KROS) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | -292.26% |
| 2022-12-31 | N/A |
| 2023-12-31 | -101319.21% |
| 2024-12-31 | -5277.55% |
| 2025-12-31 | 35.65% |
How KROS compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc. | 30.16% |
| SPRO | Spero Therapeutics Inc. | 12.83% |
| IDYA | IDEAYA Biosciences Inc. | -51.99% |
| RGNX | REGENXBIO Inc. | -113.75% |
| VYGR | Voyager Therapeutics Inc. | -296.53% |
These are five companies in the same sector as KROS with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Keros Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("KROS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | KROS | $11.20 | +5.26% | 0.16M |
| 3 | ||||
| 4 | ||||
| 5 |